Authors
Latest:
The Impact of Mergers and Acquisitions on Brand in the Life Sciences IndustryLaura Child, Head of Research and Strategy at ramarketing, discusses the importance of brand reputation and the effect brand architecture associated with merger and acquisition (M&A) can have on a company’s brand.
Latest:
The Legal Environment for IVF and Other Assistive Reproductive Technology After Alabama’s Supreme Court and Legislative DecisionsUnlike for individuals or entities providing or receiving services related to in vitro fertilization (IVF), the Alabama IVF Act does not grant immunity to manufacturers, but it limits damages for their violations to the cost of an IVF cycle.
Latest:
Expert Roundup: How Technology is Shaping the Future of Life SciencesIndustry leaders share perspectives on moving the life sciences industry forward.
Latest:
The Real Value of AI in Healthcare? Strengthening the Doctor-Patient RelationshipWhy empowering both parties with the tools and data they need to make clinical decisions should be a top priority in the AI renaissance—to bolster patient care and improve health outcomes.
Latest:
Bridging the Divide: Medical's Omnichannel MomentumHow pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.
Latest:
Moving Toward the Pharmaceutical Industry of the Future with Translational MedicineGabi Hanna, MD highlights the need for an effective therapy for acute pancreatitis.
Latest:
Executive Roundtable: Innovations in Global Pharma LabelingFive industry experts discuss labeling challenges and trends in modernization.
Latest:
CDMOs are Exploring Risk-Sharing for Resilient Growth in a BANI WorldKey industry trends and how the relationships between companies and CDMOs are evolving to better meet the challenges of a BANI world.
Latest:
The Healthcare System is Changing—So How Should We Respond?What pharma needs to do to keep up with the rise in value-based care.
Latest:
Cracking Down on Speaker ProgramsWith heightened government scrutiny on educational forums, biopharma manufacturers need a sound framework that demonstrates they are following best practices.
Latest:
EU Medical Device Supply Chains and Trade Agreements: The COVID-19 ResponseAndrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.
Latest:
How Market Access Can Determine Commercial SuccessUsing market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.
Latest:
How to Lead and Succeed in the Biosimilars SpaceKey traits needed by leaders looking to grow their organizations in the biosimilars market.
Latest:
Shedding Light on Global Pharmaceutical Supply ChainsIncrease in new treatments also brings increase in logistical challenges for pharma.
Latest:
Patients and Data Disrupt the Life Sciences IndustryDelivering better patient outcomes hinges on innovation and adaptability.
Latest:
The Promise of Agentic AI to Cut Through HCP Marketing OverwhelmPrioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively with the right message.
Latest:
A New Era in European Life Sciences InvestmentInvestments setting up sector for future success that could one day rival its US counterpart.
Latest:
How Medical Affairs Can Contribute to Successful Drug LaunchFaster launch planning leads to greater access.
Latest:
New Technologies Come with New Litigation RisksCybersecurity vulnerabilities embedded in AI and machine learning pose significant litigation risks as life sciences companies move to digital technologies.
Latest:
Navigating the European Market for Medical CannabisThere is considerable variation in the regulatory approach to medical cannabis between European countries. Yet, despite the complexity, there are clear routes to market, reports Peter Kohut.
Latest:
The Global Vaccine R&D Pipeline and Delivery ImplicationsThe current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.
Latest:
US and EU Finalize Trade Agreement with Pharma Tariffs in FocusThe pact introduces a 15% levy on most EU exports, including pharmaceuticals.
Latest:
How AI is Changing the Drug Development JourneyWhile no company has yet achieved the full promise of AI to radically accelerate time to market, meaningful strides are being made across the drug discovery funnel.
Latest:
Navigating the EU’s Joint Clinical AssessmentPathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be critical.
